Clinical Trial Update: Intravenous Immunoglobulin Therapy in Optic Neuritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravenous immunoglobulin therapy for optic neuritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Neuritis

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Optic Neuritis | Phase 3 | Status: COMPLETED